Loading…
Loading…
The decision is the second FSR Phase II conditional clearance (after Commission Decision M.11630 in the e& / PPF Telecom case, September 2024) and is the operational template most directly relevant for sovereign-wealth-fund and state-controlled-enterprise acquisitions of EU strategic industrial assets.
The Phase II investigation found two foreign-subsidy distortions under Articles 4 and 5 of Regulation (EU) 2022/2560:
1. An unlimited UAE State guarantee covering ADNOC — i.e., the absence of a hard liability cap on UAE sovereign backing of ADNOC acted as a non-market financing advantage relative to EU bidders. 2. A capital increase committed by ADNOC's state-holding parent into Covestro post-closing, traceable to non-market support, plus advantageous tax measures benefitting ADNOC.
The remedy package addresses both:
guarantee structure; this neutralises the financing-cost distortion going forward.
cooperation agreements with EU competitors in force, preventing post-acquisition unwinding of joint-development access.
license its present and future sustainability-related patents (c. 200 patents) to qualifying EU market participants on pre-established transparent terms for ten years. A template licence agreement and an eligible-licensee list (excluding direct competitors) will be published on a dedicated website. An independent Monitoring Trustee is appointed to oversee compliance and dispute resolution.
The sustainability-IP-licensing remedy is the structurally novel limb: it is the first FSR clearance to deploy forward-looking IP licensing as a structural commitment, going beyond the financing-restructuring + behavioural commitments seen in the e&/PPF template.
acquisitions** — sets precedent that DG COMP will reach for IP-licensing remedies (not only divestitures or financing restructuring) in FSR Phase II clearances of strategic-asset takeovers. Future FSR-notifiable transactions involving ADIA, Mubadala, PIF, CIC, China Investment Corporation, and large Chinese SOEs acquiring EU chemicals / semiconductors / critical-materials assets should now price an IP-licensing remedy into deal models.
forward-looking ("present and future") scope of the patent licensing commitment effectively converts what would otherwise be proprietary Covestro R&D output into an EU-market-accessible pool for the remedy duration. EU industrial bidders for green-chemistry assets (BASF, Linde, Solvay, Evonik, Arkema) gain a structural defensive lever in M&A processes against state-backed bidders.
EU-listed sustainable-chemistry and industrial-gases names; the remedy template makes future EU-asset acquisitions by non-EU SOEs procedurally costlier but does not block them.
this is not a severity-4 blocking action; severity reflects the template-setting value of the remedy structure rather than direct trade-flow impact.
template licence agreement promptly, and will US companies be excluded as "competitors"? The eligible-licensee perimeter is the load-bearing variable for downstream effect.
semiconductors (ASML, ASMI, BESI), electric-arc-furnace steel (ArcelorMittal Sestao), battery materials (Umicore)?
against future UAE sovereign actions, or is it a contractual commitment between ADNOC and the Commission only?
Recommendation (2025-01-15-eu-commission-recommendation-2025-63-outbound-investment-screening) and the parallel inbound-screening regimes operated by Member States?